EE513 Health Economic Evaluation Incorporating Mixture Cure Survival Analysis of Nivolumab Plus Ipilimumab for Previously Untreated Metastatic NSCLC
Abstract
Authors
A Griffiths R Young Y Yuan M Chaudhary A Lee J Gordon P McEwan